Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: Case report and literature review

Matteo Bordignon, Edoardo Zattra, Maria Cristina Montesco, Mauro Alaibac

Research output: Contribution to journalArticlepeer-review

Abstract

Subcorneal pustular dermatosis (SPD) [Sneddon-Wilkinson disease] is a benign and uncommon disorder characterized by a chronic, relapsing vesiculopustular eruption of unknown etiology. We present a case of SPD in a young Black woman in whom ELISA was performed to test for desmoglein 1 and 3 antigens (the first reported case of evaluation for these antigens in a patient with SPD). The test revealed the absence of both antibodies. The patient was successfully treated with topical corticosteroids and narrow-band UVB phototherapy. In this report, we review both the pathophysiology of SPD, which has yet to be clarified, and its treatment. Data obtained from our case report add further support to the hypothesis that a non-antibody-mediated mechanism is operative in SPD. The treatment of choice for SPD is dapsone. However, the combination of corticosteroids and UVB phototherapy should be considered a valid therapeutic option in patients who are not appropriate candidates for dapsone therapy.

Original languageEnglish
Pages (from-to)51-55
Number of pages5
JournalAmerican Journal of Clinical Dermatology
Volume9
Issue number1
Publication statusPublished - 2008

Keywords

  • Antibodies, diagnostic use
  • Dapsone, therapeutic use
  • Skin disorders, general

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: Case report and literature review'. Together they form a unique fingerprint.

Cite this